NOVO-B Dividend History & Analysis | 4.6% Yield
NOVO-B has a dividend yield of 4.6% and paid 11.7 DKK per share in the last 12M. Complete payout history, full analyses and peer comparison.
Top Dividend Payers in Biotechnology
| SYMBOL | MARKET CAP USD | YIELD TTM | YIELD ON COST 5y |
|---|---|---|---|
| NOVO-B CO Novo Nordisk |
217,900 M | 4.57% | 4.55% |
| ABBV NYSE AbbVie |
453,924 M | 3.06% | 6.90% |
| GILD NASDAQ Gilead Sciences |
160,547 M | 2.56% | 5.53% |
| AMGN NASDAQ Amgen |
200,502 M | 2.96% | 4.73% |
| AZN ST AstraZeneca |
268,845 M | 1.74% | 3.30% |
| HLN NYSE Haleon |
43,069 M | 1.93% | 2.69% |
| PHM MC Pharma Mar S.A. |
1,567 M | 1.23% | 1.40% |
| BIOA-B ST BioArctic (publ) |
2,815 M | 0.59% | 1.44% |
| ALK-B CO ALK-Abelló |
7,892 M | 0.75% | 1.05% |
| REGN NASDAQ Regeneron Pharmaceuticals |
68,346 M | 0.54% | 0.63% |
| SYMBOL | MARKET CAP USD | GROWTH RATE | CONSISTENCY |
|---|---|---|---|
| NOVO-B CO Novo Nordisk |
217,900 M | 26.23% | 100.0% |
| HLN NYSE Haleon |
43,069 M | 21.48% | 100.0% |
| PHM MC Pharma Mar S.A. |
1,567 M | 18.62% | 99.0% |
| AMGN NASDAQ Amgen |
200,502 M | 7.02% | 100.0% |
| ABBV NYSE AbbVie |
453,924 M | 5.25% | 100.0% |
| GILD NASDAQ Gilead Sciences |
160,547 M | 2.74% | 100.0% |
| REGN NASDAQ Regeneron Pharmaceuticals |
68,346 M | 6.24% | 100.0% |
| AZN ST AstraZeneca |
268,845 M | 3.77% | 100.0% |
NOVO-B Dividend History
Dividend Monthly Return EX date, 4.9 years of data
Average monthly dividend return by ex-dividend date. The score below shows reliability based on how consistently dividends were paid in that month.
| EX-DATE | RECORD | PAYMENT | PERIOD | DIV/SHARE | GROWTH | PAYOUT YIELD |
|---|---|---|---|---|---|---|
| 2026-03-27 | 2026-03-31 | Final | 7.95 | +112% | 3.41% | |
| 2025-08-15 | 2025-08-19 | Interim | 3.75 | -52.5% | 1.16% | |
| 2025-03-28 | 2025-04-01 | Final | 7.9 | +125.7% | 1.65% | |
| 2024-08-15 | 2024-08-19 | Interim | 3.5 | -45.3% | 0.39% | |
| 2024-03-22 | 2024-03-26 | Final | 6.4 | +6.7% | 0.72% | |
| 2023-08-18 | 2023-08-22 | Interim | 6 | -26.4% | 0.48% | |
| 2023-03-24 | 2023-03-28 | Final | 8.15 | +91.8% | 0.8% | |
| 2022-08-12 | 4.25 | -38.4% | 0.54% | |||
| 2022-03-25 | 2022-03-29 | Final | 6.9 | +97.1% | 0.95% | |
| 2021-08-16 | 2021-08-18 | Interim | 3.5 | 0% | 0.54% |
NOVO-B Dividend FAQ
As of July 2026, NOVO-B's dividend yield is 4.57%. This is calculated by dividing the trailing 12-month dividend rate (TTM rate) of 11.7 DKK by the current share price of 326.50.
As of July 2026, NOVO-B paid a dividend of 11.70 DKK in the last 12 months. The last dividend was paid on 2026-03-27 and the payout was 7.95 DKK.
NOVO-B pays dividends semi-annually. Over the last 12 months, NOVO-B has issued 2 dividend payments. The last dividend payment was made on 2026-03-27.
Based on historical data, the forecasted dividends per share for NOVO-B for the next payments are between 1.59 (-80.0%) and 9.123 (+14.8%). This represents a significant dividend cut compared to the last payment. The expected Yield for the next 12 months is about 3.28%.
The latest dividend paid per share was 7.95 DKK with an Ex-Dividend Date of 2026-03-27. The next Ex-Dividend date for Novo Nordisk (NOVO-B) is currently unknown.
The next Ex-Dividend date for Novo Nordisk (NOVO-B) is currently unknown. We automatically update the next Ex-Dividend date when it is announced.
NOVO-B's average dividend growth rate over the past 5 years is 26.2% per year. Strong growth: NOVO-B's dividend growth is outpacing inflation.
NOVO-B's 5-Year Yield on Cost is 4.55%. If you bought NOVO-B's shares at 257.17 DKK five years ago, your current annual dividend income (11.7 DKK per share, trailing 12 months) equals 4.55% of your original purchase price.
NOVO-B Payout Consistency is 100.0%. The payout consistency is a proprietary measure of how consistently a company has paid dividends over its lifetime and blends growth rate, number of dividend payments, interruptions or lowering dividends into one number. Very consistent: Novo Nordisk has a strong track record of consistent dividend payments over its lifetime.
NOVO-B's 4.57% Dividend Yield is considered as good. Make sure the dividend is sustainable: Check the Payouts-Ratio over time.
The Dividend Payout Ratio of NOVO-B is 50.6%. Healthy - Leaves room for growth and provides some protection to maintain dividends even in a recession.
NOVO-B's Overall Dividend Rating is 75.96%. Ratings surpassing 65% are regarded as acceptable, exceeding 75% are favorable and surpassing 85% are strong.
NOVO-B Outstanding Shares Analysis
Key Metric Definitions
Annual dividend per share divided by current share price.
Percentage of earnings paid as dividends. Below 60% = safe, above 100% = unsustainable.
Percentage of Free Cash Flow paid as dividends. More reliable than Payout Ratio since it measures actual cash.
Compound annual growth rate of dividends over the last 5 years.
Reliability of dividend payments over lifetime. Penalizes cuts and pauses.
Your effective yield if you bought 5 years ago. Shows dividend growth impact over time.
Consecutive years of dividend payments. 25+ years = Dividend Aristocrat.
Proprietary score (0-100) combining yield, growth, safety and consistency.
Last update: 2026-07-24 02:37 UTC